Guzmán María G, Kourí Gustavo
Virology Department, PAHO/WHO Collaborating Center for Viral Diseases, Pedro Kouri Tropical Medicine Institute, Autopista Novia del Mediodia, Km 6, PO Box Marianao 13, Ciudad Habana, Cuba.
Lancet Infect Dis. 2002 Jan;2(1):33-42. doi: 10.1016/s1473-3099(01)00171-2.
This review is an update of dengue and dengue haemorrhagic fever (DHF) based on international and Cuban experience. We describe the virus characteristics and risk factors for dengue and DHF, and compare incidence and the case fatality rates in endemic regions (southeast Asia, western Pacific, and the Americas). The clinical picture and the pathogenesis of the severe disease are explained. We also discuss the viral, individual, and environmental factors that determine severe disease. Much more research is necessary to clarify these mechanisms. Also reviewed are methods for viral isolation and the serological, immunohistochemical, and molecular methods applied in the diagnosis of the disease. We describe the status of vaccine development and emphasise that the only alternative that we have today to control the disease is through control of its vector Aedes aegypti.
本综述基于国际和古巴的经验,对登革热和登革出血热(DHF)进行了更新。我们描述了登革热和登革出血热的病毒特征及危险因素,并比较了流行地区(东南亚、西太平洋和美洲)的发病率和病死率。文中解释了重症疾病的临床表现和发病机制。我们还讨论了决定重症疾病的病毒、个体和环境因素。需要开展更多研究以阐明这些机制。本文还综述了病毒分离方法以及用于该疾病诊断的血清学、免疫组织化学和分子方法。我们描述了疫苗研发的现状,并强调目前我们控制该疾病的唯一办法是控制其病媒埃及伊蚊。